L. Van Gaal

Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide

Arne Astrup, Raffaele Carraro, Nick Finer et al. · International Journal of Obesity · 2011 · 757 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial

Thomas R. Pieber, Bruce W. Bode, Young Min Cho et al. · The Lancet Diabetes & Endocrinology · 2019 · 274 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +9

Sleep-disordered breathing in overweight and obese children and adolescents: prevalence, characteristics and the role of fat distribution

Stijn Verhulst, N. Schrauwen, D. Haentjens et al. · Archives of Disease in Childhood · 2006 · 267 citations · Full text

Medicine, Pediatrics, Pediatric Pulmonology +13

A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects

John Wilding, L. Van Gaal, A Rissanen et al. · International Journal of Obesity · 2004 · 225 citations

Medicine, Pharmacology, Pharmacotherapy +11

Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults

Michael E. J. Lean, Raffaele Carraro, Nick Finer et al. · International Journal of Obesity · 2013 · 209 citations · Full text

Agriculture, Nutritional Sciences, Pharmacotherapy +17